Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Utility of DLMO in the Treatment of Delayed Sleep-Wake Phase Disorder: A Randomized Trial

NCT03715465 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT03715465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03715465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Utility of DLMO in the Treatment of Delayed Sleep-Wake Phase Disorder: A Randomized Trial
Lead sponsor
University of Michigan
Phase
Phase 3
Overall status
Completed
Start date
February 15, 2019
Completion date
November 5, 2021
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delayed sleep phase syndrome